Diabetes & Endocrine Disorders

A Wealth of Experience

We have collaborated with our clients on projects to research diabetes and endocrine disorders, diabetes and endocrine treatments, and complications and comorbidities of diabetes and endocrine disorders. Our experience includes:

  • Type I diabetes
  • Type 2 diabetes
  • Microvascular complications in diabetes including:
    • Diabetic retinopathy
    • Diabetic nephropathy
    • Peripheral neuropathy
  • Macrovascular complications including:
    • Cardiovascular events related to diabetes
    • Peripheral vascular disease
    • Diabetic foot ulcers
  • Obesity

Types of Projects

We have implemented studies to help our clients develop strategies in the diabetes market and to develop and gain market access for products to treat diabetes and endocrine disorders and complications arising from treatment of diabetes. Recent projects have included:

Our Experts

Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Sean Candrilli
Vice President, Health Economics
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Katherine Hicks
Director, Health Economics
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Mary Anthony
Director, Epidemiology
Costel Chirila
Director, Biostatistics
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Alicia Gilsenan
Senior Director and Head, Epidemiology
Andrea Margulis
Director, Epidemiology
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Emma Hawe
Head, Data Analytics and Design Strategy
Katherine Stull
Director, Health Economics
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Christine Poulos
Senior Economist and Head, Health Preference Assessment
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Juliana Meyers
Director, Health Economics
Bintu Sherif
Director, Biostatistics
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Will Herring
Senior Director, Health Economics
Patricia Sacco
Executive Director, Surveys and Observational Studies
Keith Davis
Senior Director, Health Economics
Caroline Ling
Senior Director and HTA Specialist, Market Access and Outcomes Strategy
Sorrel Wolowacz
Head, European Health Economics
Michele Wilson
Senior Director, Health Economic
Lia Gutierrez
Senior Director, Epidemiology
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Manel Pladevall-Vila
Senior Director, Epidemiology
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Annete Njue
Director, Market Access and Outcomes Strategy
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy

Selected Recent Diabetes & Endocrine Disorders Publications

Zhou CK, Dinh J, Danysh HE, Johannes C, Gutierrez L, Schmid R, Arana A, Kaye JA, Pladevall-Vila M, Garcia-Albeniz X, Gangemi K, Yin R, Ruzafa JC, Gilsenan A, Beachler DC. Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer among patients with type 2 diabetes: a pilot study. Poster presented at the 35th Annual ICPE Conference; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):317. doi: 10.1002/pds.4864.